When OCA becomes the right option

A significant cartilage or bone defect from a knee injury — whether from an acute impact, an osteochondral fracture, or a condition such as osteochondritis dissecans (OCD) — leaves behind a focal hole in an otherwise relatively healthy joint. That distinction matters when choosing a repair technique.

Fresh osteochondral allograft (OCA) transplantation addresses this pattern directly. A precisely sized plug of donor bone and cartilage — harvested from a tissue-matched allograft — is press-fitted into the defect, replacing not just the cartilage surface but the underlying subchondral bone in a single operation. There is no cell-culture stage, no second procedure. The graft arrives as mature hyaline cartilage, which is the tissue the knee is designed to run on.

OCA is generally indicated where defects are too large for autograft techniques to cover adequately — typically above four to six square centimetres — or where a previous repair has broken down. Posttraumatic lesions fit this profile well: they tend to be contained within one compartment, with relatively intact surrounding tissue, rather than the diffuse wear pattern seen in established osteoarthritis, for which OCA is not appropriate.

Younger, active patients are generally considered stronger candidates. The factors most closely associated with graft failure — older age, higher body mass index, concurrent ligament reconstruction or osteotomy, and poor rehabilitation adherence — are less commonly present in this group. For them, OCA is a joint-preservation strategy: the aim is durable, pain-free function and, where possible, the avoidance or long-term delay of joint replacement.

Survivorship figures: ideal cohort versus the wider picture

Survivorship rates for OCA vary considerably depending on who is being treated, and understanding that spread is more useful than any single headline figure.

The strongest evidence comes from a cohort study of 91 patients (97 knees) selected on strict criteria: age 30 or under (mean age 20), an isolated unipolar lesion on the femoral condyle or trochlea smaller than 8 cm², arising from trauma or OCD, with no prior failed cartilage repair. In this group, graft survivorship reached 99% at both five and ten years, with 93% of patients reporting satisfaction. These are not marketing claims — they reflect a tightly defined clinical profile, and that specificity is precisely why the figures are so high.

When the same procedure is studied across a broader population — mixed ages, varied defect sizes, multiple underlying diagnoses — the picture shifts. Landmark mixed-indication series report approximately 85% survivorship at ten years, falling to around 75% at fifteen years and roughly 60% at twenty-five years. These figures remain meaningful: a joint preserved for two decades in a patient who would otherwise have faced early arthroplasty is a substantive outcome. But they represent a realistic floor, not a match for the ideal-cohort ceiling.

In practice, where a patient sits within that range depends on age, lesion characteristics, and the absence of compounding factors — all of which a consultant assessment can evaluate against the published evidence. It is also worth noting that these survivorship figures describe graft durability, not the full picture of functional recovery, which is a related but separate question.

Return to sport and functional recovery

Getting back to the sports and activities that define daily life is often the question that matters most, and the evidence here is broadly encouraging.

Across general OCA cohorts at a mean six-year follow-up, 75.2% of patients returned to sport or recreational activity, and 71% achieved 'very good' to 'excellent' knee function. In dedicated athletic cohorts the figures improve: approximately 88% returned to sport, with 79% reaching their pre-injury performance level — a meaningful distinction, since resuming a sport and competing at the same standard are not the same thing.

Patient-reported outcome scores — standardised questionnaires that capture how the knee feels and performs in daily life — improve significantly for both men and women by five years. One useful marker in these tools is the 'patient acceptable symptom state' threshold: the point at which patients say the result was worth having. Female patients reach this point, as well as the minimum change needed to feel meaningfully better, at higher rates than male patients. This finding is worth raising in pre-operative discussions rather than assuming outcomes are uniform across sexes.

Biomechanically, OCA consistently restores knee range of movement to above 120°, with improvements in strength and gait also reported — all within a single operation. Because there is no cell-culture stage, patients avoid the additional waiting period between biopsy and re-implantation that both ACI and MACI require.

Realistic return timelines depend on defect size, whether a corrective procedure such as osteotomy was performed at the same time, and adherence to the rehabilitation programme — factors that a consultant can weigh against the published evidence at assessment.

How lesion complexity shifts the odds

Not all OCA cases carry the same odds, and three variables — lesion geometry, joint surface involvement, and whether a previous repair has already been attempted — produce a clear gradient that shapes counselling conversations.

Isolated unipolar condyle grafts

For a primary graft placed on a single femoral surface, ten-year survivorship sits between 88% (medial femoral condyle) and 92.9% (lateral femoral condyle) in a 319-patient series with a mean age of 30.5 years. The difference between the two condyles is not statistically significant, which simplifies decision-making when the defect location is determined by injury pattern rather than surgical preference.

Secondary OCA after a failed index repair

When OCA is used to rescue a failed earlier procedure, the picture changes. In a systematic review of 349 patients (mean age 34.6 years), five-year survivorship ranged from 79% to 87.8%, falling to 61–82% at ten years — notably wider bands, reflecting greater case heterogeneity. Defect size is the sharpest predictor: grafts covering 9–10 cm² carry a 39% failure rate, against a 16.6% overall rate across the group.

Large bipolar lesions

The most demanding scenario involves cartilage damage on both sides of the joint — the thigh bone and the shin bone simultaneously. In a series of 89 knees with a mean defect area of 16.7 cm², survivorship was 73.8% at five years, 66.6% at ten years, and 58.9% at fifteen years, with a mean time to failure of 4.8 years. Bipolar involvement is the single factor most likely to move a young patient's prognosis toward the population floor rather than the ideal-cohort ceiling.

Dominant failure mechanisms across all groups are OCA bone failure, meniscal complications, and joint disease progression. The risk factors that amplify these — older age, higher BMI, and poor post-operative adherence — tend to be lower-burden in younger active patients, which is part of why that group trends toward better results. Where lower-limb malalignment is also present, adding a concurrent distal femoral osteotomy has produced significant IKDC improvements at mean 7.1-year follow-up, extending OCA's reach into more complex posttraumatic presentations. All of this reinforces why a detailed biomechanical and imaging assessment matters before settling on a plan.

What to expect from the procedure and graft logistics

One logistical detail that often surprises patients is that donor and recipient sex need not match. A study of 285 patients found no significant difference in graft survival between sex-matched and sex-mismatched pairings (p=0.70), which means the pool of compatible grafts is broader than many assume — a practical benefit when scheduling depends on tissue availability.

Fresh allograft viability is maintained through chondrocyte preservation protocols during storage. The quality of those protocols — including temperature management and storage duration — varies between tissue banks and is worth raising at consultation when choosing a centre. Asking about viability standards is a reasonable part of the consent conversation rather than a reason to avoid the procedure.

Where posttraumatic injury has also shifted the mechanical axis of the knee, a distal femoral osteotomy can be performed in the same operative session as the graft. Adding realignment does increase the complexity of the procedure, but it addresses the loading environment the graft will work within — which bears directly on long-term protection. The outcomes evidence for this combination is discussed in the previous section.

Rehabilitation after OCA is phased, and return-to-sport expectations are best anchored to functional milestones — strength recovery, range of movement, and dynamic control — rather than fixed calendar dates. How quickly those milestones are reached depends on defect size, whether a concurrent procedure was performed, and consistent adherence throughout recovery. A consultant and physiotherapist can map those benchmarks to individual circumstances at assessment.

Secondary procedures, TKA conversion, and planning for the long term

Honest counselling about secondary procedures matters as much as any survivorship figure. Over long-term follow-up, approximately 39–43% of OCA recipients undergo at least one further knee intervention — arthroscopic debridement, meniscal work, or supplementary cartilage procedures. The majority of these address joint maintenance rather than graft failure; the graft itself may remain intact throughout.

The figure that belongs unambiguously in every pre-operative consent discussion is the eventual total knee arthroplasty conversion rate of approximately 16%. That is not a failure of the procedure — it reflects the natural history of a damaged joint tracked across many years — but patients considering OCA at 25 or 30 deserve to know it before they commit.

Reframed against that backdrop, OCA's purpose becomes clearer: preserving a functioning native knee for a further decade or more, deferring replacement surgery to an age at which an implant's longevity profile is better matched to what remains ahead. For a young patient with a contained posttraumatic lesion, that is a clinically meaningful gain in its own right.

The evidence underpinning these outcomes is predominantly Level III and IV — case series and retrospective registries rather than randomised trials comparing OCA head-to-head with MACI or autograft in posttraumatic-specific cohorts. That caveat is worth naming, but it does not contradict a consistent direction across multiple large datasets. What those datasets collectively suggest is that the further a patient departs from the ideal profile — younger, unipolar, contained, arising directly from injury — the more the odds shift toward the population floor. Understanding where one sits on that gradient is, ultimately, the purpose of the assessment conversation.

1. [1] Osteochondral Allograft Transplantation of the Knee in 'Ideal' Candidates: Clinical Outcomes and Graft Survivorship. (2020). https://doi.org/10.1177/2325967120s00501 https://doi.org/10.1177/2325967120s00501
2. [2] Poster 256: Is There a Difference Between Medial and Lateral Femoral Condyle Allografts? An Outcome and Survivorship Analysis. (2024). https://doi.org/10.1177/2325967124s00225 https://doi.org/10.1177/2325967124s00225
3. [3] Osteochondral Allograft Transplantation as a Salvage Procedure After Failed Index Cartilage Surgery of the Knee: A Systematic Review. (2025). https://doi.org/10.1177/03635465241238466 https://doi.org/10.1177/03635465241238466
4. [4] Midterm Survivorship and Clinical Outcomes in Fresh Osteochondral Allograft Transplantation for the Treatment of Large Bipolar Lesions of the Knee. (2025). https://doi.org/10.1177/03635465241313139 https://doi.org/10.1177/03635465241313139
5. [5] Sex-Based Differences in Clinically Significant Outcome Achievement Following Primary Osteochondral Allograft Transplantation of the Knee at a Minimum 5-Year Follow-up. (2025). https://doi.org/10.1177/03635465251338219 https://doi.org/10.1177/03635465251338219
6. [6] Functional outcomes and survivorship of distal femoral osteotomy with cartilage restoration of the knee. (2021). https://doi.org/10.1016/J.JCJP.2021.100004 https://doi.org/10.1016/J.JCJP.2021.100004
7. [7] Mid-term failure rates, timing, and mechanisms for osteochondral allograft transplantation in the knee: Characterizing risk factors and identifying modifiable variables. (2025). https://doi.org/10.1016/j.jor.2025.03.040 https://doi.org/10.1016/j.jor.2025.03.040
8. [8] The biomechanical and functional outcomes of fresh osteochondral allograft for the knee: A systematic review. (2025). https://doi.org/10.1016/j.jcot.2025.102983 https://doi.org/10.1016/j.jcot.2025.102983
9. [9] Donor-recipient sex mismatch does not affect graft survivorship after knee osteochondral allograft transplantation. (2025). https://doi.org/10.1016/j.knee.2025.05.029 https://doi.org/10.1016/j.knee.2025.05.029